Back to Results
First PageMeta Content
Research / Clinical research / Pharmaceutical industry / Pharmacology / Drug safety / Investigational New Drug / Center for Biologics Evaluation and Research / Center for Drug Evaluation and Research / New Drug Application / Food and Drug Administration / Pharmaceutical sciences / Medicine


Guidance for Industry Q&A Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-Derived Products
Add to Reading List

Open Document

File Size: 14,19 KB

Share Result on Facebook

City

Rockville / /

Facility

Rockville Pike / /

/

IndustryTerm

clinical protocols / /

MedicalTreatment

clinical protocols / /

Organization

U.S. Department of Health and Human Services / office of Review Management ORM / U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research / HFM-40 Center for Biologics Evaluation / Food and Drug Administration Center for Drug Evaluation and Research / Food and Drug Administration / Center for Biologics Evaluation and Research / office of Training / Center for Biological Evaluation and Research / office of Communication / Training and Manufacturers Assistance / Training and Communications Division of Communications Management Drug Information Branch / /

/

ProvinceOrState

Maryland / /

Technology

Biotechnology / /

URL

http /

SocialTag